Nuvation Bio Inc (NYSE: NUVB) is -24.06% lower on its value in year-to-date trading and has touched a low of $1.54 and a high of $3.97 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NUVB stock was last observed hovering at around $2.02 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $2.02, the stock is 9.34% and -0.33% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.19 million and changing 0.00% at the moment leaves the stock -22.21% off its SMA200. NUVB registered -31.99% loss for a year compared to 6-month loss of -11.01%. The firm has a 50-day simple moving average (SMA 50) of $2.0266 and a 200-day simple moving average (SMA200) of $2.5968.
The stock witnessed a -3.35% gain in the last 1 month and extending the period to 3 months gives it a -22.01%, and is 21.69% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.16% over the week and 8.40% over the month.
Nuvation Bio Inc (NUVB) has around 220 employees, a market worth around $686.13M and $7.87M in sales. Profit margin for the company is -7213.76%. Distance from 52-week low is 31.17% and -49.12% from its 52-week high. The company has generated returns on investments over the last 12 months (-122.20%).
with sales reaching $416.67k over the same period.The EPS is expected to grow by 73.12% this year, but quarterly earnings will post 72.24% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Nuvation Bio Inc (NUVB) Top Institutional Holders
213.0 institutions hold shares in Nuvation Bio Inc (NUVB), with institutional investors hold 80.16% of the company’s shares. The shares outstanding are 336.84M, and float is at 226.88M with Short Float at 14.15%. Institutions hold 58.83% of the Float.
The top institutional shareholder in the company is FMR LLC with over 28.82 million shares valued at $84.16 million. The investor’s holdings represent 11.7767% of the NUVB Shares outstanding. As of 2024-06-30, the second largest holder is ECOR1 CAPITAL, LLC with 19.21 million shares valued at $56.09 million to account for 7.8491 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 16.24 million shares representing 6.6343% and valued at over $47.41 million, while OMEGA FUND MANAGEMENT, LLC holds 5.4245 of the shares totaling 13.28 million with a market value of $38.77 million.
Nuvation Bio Inc (NUVB) Insider Activity
The most recent transaction is an insider purchase by Hung David, the company’s PRESIDENT AND CEO. SEC filings show that Hung David bought 300,000 shares of the company’s common stock on Apr 07 ’25 at a price of $1.62 per share for a total of $0.49 million. Following the purchase, the insider now owns 58.78 million shares.
Nuvation Bio Inc disclosed in a document filed with the SEC on Apr 04 ’25 that Hung David (PRESIDENT AND CEO) bought a total of 200,000 shares of the company’s common stock. The trade occurred on Apr 04 ’25 and was made at $1.66 per share for $0.33 million. Following the transaction, the insider now directly holds 58.48 million shares of the NUVB stock.
Still, SEC filings show that on Apr 01 ’25, Mashal Robert (Director) acquired 100,000 shares at an average price of $1.67 for $0.17 million. The insider now directly holds 200,000 shares of Nuvation Bio Inc (NUVB).
